praziquantel has been researched along with Central Nervous System Diseases in 22 studies
azinox: Russian drug
Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty seven patients with neurocysticercosis were treated with praziquantel in progressive doses reaching 50 mg/kg/day associated with dexamethasone for 21 days." | 7.68 | [Treatment of neurocysticercosis with praziquantel]. ( Costa, JM; Macedo, V; Mello, P; Souza, HA; Vianna, LG, 1990) |
| "Cerebrospinal fluid (CSF) and serum samples of 10 patients with neurocysticercosis under treatment by praziquantel were studied in four occasions: before treatment (day 0) and during treatment on three occasions (days 1, 7 and 21)." | 7.67 | [ELISA (IgG and IgM) of the CSF and serum in neurocysticercosis under treatment with praziquantel: comparison with complement fixation reactions and immunofluorescence]. ( Costa, JM; Livramento, JA; Machado, LR; Nóbrega, JP; Spina-França, A, 1985) |
| "In 10 patients with neurocysticercosis (NC), an assessment was made of the praziquantel (PZQ) concentration in the cerebrospinal fluid (CSF), in non-deproteinized serum and in protein-free serum: before administration of the drug and the 1st." | 7.67 | Praziquantel in the cerebrospinal fluid in neurocysticercosis. ( de Rezende, GL; Diekmann, HW; Groll, E; Livramento, JA; Machado, LR; Nóbrega, JP; Spina-França, A, 1985) |
| "The study is based on 371 cerebrospinal fluid (CSF) samples and 324 serum samples from 40 patients with neurocysticercosis (NC) submitted to treatment with praziquantel." | 4.77 | [A cerebrospinal fluid syndrome in neurocysticercosis]. ( Livramento, JA, 1987) |
| "Twenty seven patients with neurocysticercosis were treated with praziquantel in progressive doses reaching 50 mg/kg/day associated with dexamethasone for 21 days." | 3.68 | [Treatment of neurocysticercosis with praziquantel]. ( Costa, JM; Macedo, V; Mello, P; Souza, HA; Vianna, LG, 1990) |
| "Cerebrospinal fluid (CSF) and serum samples of 10 patients with neurocysticercosis under treatment by praziquantel were studied in four occasions: before treatment (day 0) and during treatment on three occasions (days 1, 7 and 21)." | 3.67 | [ELISA (IgG and IgM) of the CSF and serum in neurocysticercosis under treatment with praziquantel: comparison with complement fixation reactions and immunofluorescence]. ( Costa, JM; Livramento, JA; Machado, LR; Nóbrega, JP; Spina-França, A, 1985) |
| "In 10 patients with neurocysticercosis (NC), an assessment was made of the praziquantel (PZQ) concentration in the cerebrospinal fluid (CSF), in non-deproteinized serum and in protein-free serum: before administration of the drug and the 1st." | 3.67 | Praziquantel in the cerebrospinal fluid in neurocysticercosis. ( de Rezende, GL; Diekmann, HW; Groll, E; Livramento, JA; Machado, LR; Nóbrega, JP; Spina-França, A, 1985) |
| "Neurocysticercosis is the most important parasitic infection of the nervous system in countries of the third world." | 2.38 | Neurocysticercosis. An introduction with special emphasis on new developments in pharmacotherapy. ( Overbosch, D, 1992) |
| "Cysticercosis is the most common parasite affecting the central nervous system and is a serious health problem in many parts of the world." | 1.27 | Cysticercosis: etiology and nursing care. ( Minnick, A, 1986) |
| "Treatment with Praziquantel reduced the patient's intellectual deterioration, but hydrocephalus developed." | 1.27 | Severe dementia associated with neurocysticercosis. ( Ardila, A; Penagos, B; Rosselli, A; Rosselli, M, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (54.55) | 18.7374 |
| 1990's | 8 (36.36) | 18.2507 |
| 2000's | 1 (4.55) | 29.6817 |
| 2010's | 1 (4.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mealey, KL | 1 |
| Burke, NS | 1 |
| Friedman, J | 1 |
| Mates, S | 1 |
| Blanchard, TJ | 1 |
| Milne, LM | 1 |
| Pollok, R | 1 |
| Cook, GC | 1 |
| St Geme, JW | 1 |
| Maldonado, YA | 1 |
| Enzmann, D | 1 |
| Hotez, PJ | 1 |
| Overturf, GD | 1 |
| Schantz, PM | 1 |
| Maiti, B | 1 |
| Fong, GC | 1 |
| Cheung, RT | 1 |
| Chang, GY | 1 |
| Ko, DY | 1 |
| Overbosch, D | 1 |
| Antoniuk, SA | 1 |
| Bruck, I | 1 |
| Wittig, E | 1 |
| Accorsi, A | 1 |
| Vianna, LG | 1 |
| Macedo, V | 1 |
| Mello, P | 1 |
| Souza, HA | 1 |
| Costa, JM | 2 |
| Bittencourt, PR | 1 |
| Costa, AJ | 1 |
| Oliveira, TV | 1 |
| Gracia, CM | 1 |
| Gorz, AM | 1 |
| Mazer, S | 1 |
| Livramento, JA | 3 |
| De Carvalho-Filho, P | 1 |
| Arruda, OM | 1 |
| De Melo-Souza, SE | 1 |
| Ciferri, F | 1 |
| Minnick, A | 1 |
| Alarcón, F | 1 |
| Pérez, Y | 1 |
| Banda, H | 1 |
| Krivoy, A | 1 |
| Casale, E | 1 |
| Valdivia, RD | 1 |
| Silva, V | 1 |
| Gonzalez, A | 1 |
| Rosselli, A | 1 |
| Rosselli, M | 1 |
| Ardila, A | 1 |
| Penagos, B | 1 |
| Levin, JA | 1 |
| Smith, JG | 1 |
| Machado, LR | 2 |
| Nóbrega, JP | 2 |
| Spina-França, A | 2 |
| Lé, CT | 1 |
| Igra, J | 1 |
| Diekmann, HW | 1 |
| Groll, E | 1 |
| de Rezende, GL | 1 |
4 reviews available for praziquantel and Central Nervous System Diseases
| Article | Year |
|---|---|
Neurocysticercosis--an update.
Topics: Albendazole; Anthelmintics; Antiplatyhelmintic Agents; Central Nervous System Diseases; Cysticercosi | 1995 |
Neurocysticercosis. An introduction with special emphasis on new developments in pharmacotherapy.
Topics: Albendazole; Central Nervous System Diseases; Cimetidine; Cysticercosis; Diagnosis, Differential; Di | 1992 |
Clinical, radiological and cerebrospinal fluid presentation of neurocysticercosis: a prospective study.
Topics: Adolescent; Adult; Central Nervous System Diseases; Child; Child, Preschool; Cysticercosis; Female; | 1990 |
[A cerebrospinal fluid syndrome in neurocysticercosis].
Topics: Adolescent; Adult; Animals; Antibodies, Helminth; Antibody Formation; Central Nervous System Disease | 1987 |
18 other studies available for praziquantel and Central Nervous System Diseases
| Article | Year |
|---|---|
Identification of a nonsense mutation in feline ABCB1.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Cat Diseases; Cats; Central Nervous System D | 2015 |
Praziquantel therapy for cysticercosis.
Topics: Central Nervous System Diseases; Cysticercosis; Humans; Isoquinolines; Praziquantel | 1983 |
Early chemotherapy of imported neuroschistosomiasis.
Topics: Adult; Central Nervous System Diseases; Female; Humans; Magnetic Resonance Imaging; Praziquantel; Sc | 1993 |
Consensus: diagnosis and management of neurocysticercosis in children.
Topics: Adult; Albendazole; Brain; Central Nervous System Diseases; Child; Cysticercosis; Dexamethasone; Fec | 1993 |
Caution with praziquantel in neurocysticercosis.
Topics: Adult; Antiplatyhelmintic Agents; Central Nervous System Diseases; Cerebral Infarction; Cysticercosi | 1997 |
Isolated Echinococcus granulosus hydatid cyst in the CNS with severe reaction to treatment.
Topics: Aged; Antiplatyhelmintic Agents; Central Nervous System Diseases; Echinococcosis; Humans; Male; Praz | 2000 |
[Neurocysticercosis in childhood. II. Computed tomography of 24 patients according to symptomatic and praziquantel treatment].
Topics: Adolescent; Central Nervous System Diseases; Child; Child, Preschool; Cysticercosis; Humans; Infant; | 1991 |
[Treatment of neurocysticercosis with praziquantel].
Topics: Adolescent; Adult; Central Nervous System Diseases; Cysticercosis; Dexamethasone; Drug Therapy, Comb | 1990 |
[Periodic lateralized epileptiform discharges in neurocysticercosis].
Topics: Central Nervous System Diseases; Child; Cysticercosis; Electroencephalography; Epilepsy, Temporal Lo | 1989 |
Delayed CSF reaction to praziquantel.
Topics: Adult; Central Nervous System Diseases; Humans; Male; Praziquantel; Syndrome; Time Factors | 1988 |
Cysticercosis: etiology and nursing care.
Topics: Central Nervous System Diseases; Cysticercosis; Emigration and Immigration; Humans; Nursing Assessme | 1986 |
Praziquantel and dexamethasone.
Topics: Adult; Aged; Central Nervous System Diseases; Cysticercosis; Dexamethasone; Female; Humans; Male; Mi | 1988 |
Parasitosis and mycosis of the central nervous system: 20 years of experience.
Topics: Central Nervous System Diseases; Child; Child, Preschool; Cysticercosis; Female; Humans; Infant; Ket | 1988 |
Severe dementia associated with neurocysticercosis.
Topics: Adolescent; Aphasia; Central Nervous System Diseases; Cysticercosis; Dementia; Dexamethasone; Female | 1988 |
Praziquantel in the treatment of cysticercosis.
Topics: Central Nervous System Diseases; Cysticercosis; Humans; Praziquantel | 1986 |
[ELISA (IgG and IgM) of the CSF and serum in neurocysticercosis under treatment with praziquantel: comparison with complement fixation reactions and immunofluorescence].
Topics: Adolescent; Adult; Central Nervous System Diseases; Complement Fixation Tests; Cysticercosis; Enzyme | 1985 |
Shifting CNS symptoms in a chronic alcoholic.
Topics: Adult; Alcoholism; Central Nervous System Diseases; Cysticercosis; Dexamethasone; Humans; Male; Phen | 1985 |
Praziquantel in the cerebrospinal fluid in neurocysticercosis.
Topics: Adolescent; Adult; Blood-Brain Barrier; Central Nervous System Diseases; Cysticercosis; Female; Huma | 1985 |